This drug is significantly more potent than Tirzepatide at GIP-R agonism which means it further enhances any of the GIP-R AND GLP-1 effects in a synergistic manner
By comparison, it took statins 17 years to reach this level of market penetration, Henry Dimbleby reported in the Financial Times
Much like other treatments such as Mounjaro and Nevolat, Wegovy follows a recommended dosage schedule designed to minimise the potential impact of side effects
Meanwhile, three MHRA-licensed treatments including, since June, the UKs first weight loss tablet can be assessed and started within days, under the supervision of a registered pharmacist who is accountable for your care
The easy one
Many patients taking GLP-1 medications are older, vasculopathic, and already carry significant ocular risk factors, said Rishi P